473 related articles for article (PubMed ID: 26365179)
1. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
Dupuy F; Tabariès S; Andrzejewski S; Dong Z; Blagih J; Annis MG; Omeroglu A; Gao D; Leung S; Amir E; Clemons M; Aguilar-Mahecha A; Basik M; Vincent EE; St-Pierre J; Jones RG; Siegel PM
Cell Metab; 2015 Oct; 22(4):577-89. PubMed ID: 26365179
[TBL] [Abstract][Full Text] [Related]
2. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.
Kim JW; Tchernyshyov I; Semenza GL; Dang CV
Cell Metab; 2006 Mar; 3(3):177-85. PubMed ID: 16517405
[TBL] [Abstract][Full Text] [Related]
3. PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1α.
Wei Y; Zhang D; Shi H; Qian H; Chen H; Zeng Q; Jin F; Ye Y; Ou Z; Guo M; Guo B; Chen T
Genes Dis; 2024 Jul; 11(4):101041. PubMed ID: 38560503
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modeling links Wnt signaling to emergent patterns of metabolism in colon cancer.
Lee M; Chen GT; Puttock E; Wang K; Edwards RA; Waterman ML; Lowengrub J
Mol Syst Biol; 2017 Feb; 13(2):912. PubMed ID: 28183841
[TBL] [Abstract][Full Text] [Related]
5. The Ratio of Key Metabolic Transcripts Is a Predictive Biomarker of Breast Cancer Metastasis to the Lung.
Mathur D; Liao C; Lin W; La Ferlita A; Alaimo S; Taylor S; Zhong Y; Iacobuzio-Donahue C; Ferro A; Xavier JB
Cancer Res; 2023 Oct; 83(20):3478-3491. PubMed ID: 37526524
[TBL] [Abstract][Full Text] [Related]
6. PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs.
Andrzejewski S; Klimcakova E; Johnson RM; Tabariès S; Annis MG; McGuirk S; Northey JJ; Chénard V; Sriram U; Papadopoli DJ; Siegel PM; St-Pierre J
Cell Metab; 2017 Nov; 26(5):778-787.e5. PubMed ID: 28988825
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis.
Lehuédé C; Dupuy F; Rabinovitch R; Jones RG; Siegel PM
Cancer Res; 2016 Sep; 76(18):5201-8. PubMed ID: 27587539
[TBL] [Abstract][Full Text] [Related]
8. Differences in Metabolic Programming Define the Site of Breast Cancer Cell Metastasis.
Döppler H; Storz P
Cell Metab; 2015 Oct; 22(4):536-7. PubMed ID: 26445507
[TBL] [Abstract][Full Text] [Related]
9. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis.
Christen S; Lorendeau D; Schmieder R; Broekaert D; Metzger K; Veys K; Elia I; Buescher JM; Orth MF; Davidson SM; Grünewald TG; De Bock K; Fendt SM
Cell Rep; 2016 Oct; 17(3):837-848. PubMed ID: 27732858
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
Vincent EE; Sergushichev A; Griss T; Gingras MC; Samborska B; Ntimbane T; Coelho PP; Blagih J; Raissi TC; Choinière L; Bridon G; Loginicheva E; Flynn BR; Thomas EC; Tavaré JM; Avizonis D; Pause A; Elder DJ; Artyomov MN; Jones RG
Mol Cell; 2015 Oct; 60(2):195-207. PubMed ID: 26474064
[TBL] [Abstract][Full Text] [Related]
12. Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.
Cyr-Depauw C; Northey JJ; Tabariès S; Annis MG; Dong Z; Cory S; Hallett M; Rennhack JP; Andrechek ER; Siegel PM
Mol Cell Biol; 2016 May; 36(10):1509-25. PubMed ID: 26976638
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.
Herranz D; Ambesi-Impiombato A; Sudderth J; Sánchez-Martín M; Belver L; Tosello V; Xu L; Wendorff AA; Castillo M; Haydu JE; Márquez J; Matés JM; Kung AL; Rayport S; Cordon-Cardo C; DeBerardinis RJ; Ferrando AA
Nat Med; 2015 Oct; 21(10):1182-9. PubMed ID: 26390244
[TBL] [Abstract][Full Text] [Related]
14. PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model.
Du J; Yang M; Chen S; Li D; Chang Z; Dong Z
Oncogene; 2016 Jun; 35(25):3314-23. PubMed ID: 26455327
[TBL] [Abstract][Full Text] [Related]
15. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
16. MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.
Altman BJ; Hsieh AL; Sengupta A; Krishnanaiah SY; Stine ZE; Walton ZE; Gouw AM; Venkataraman A; Li B; Goraksha-Hicks P; Diskin SJ; Bellovin DI; Simon MC; Rathmell JC; Lazar MA; Maris JM; Felsher DW; Hogenesch JB; Weljie AM; Dang CV
Cell Metab; 2015 Dec; 22(6):1009-19. PubMed ID: 26387865
[TBL] [Abstract][Full Text] [Related]
17. Fundamentals of cancer metabolism.
DeBerardinis RJ; Chandel NS
Sci Adv; 2016 May; 2(5):e1600200. PubMed ID: 27386546
[TBL] [Abstract][Full Text] [Related]
18. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
Peng F; Wang JH; Fan WJ; Meng YT; Li MM; Li TT; Cui B; Wang HF; Zhao Y; An F; Guo T; Liu XF; Zhang L; Lv L; Lv DK; Xu LZ; Xie JJ; Lin WX; Lam EW; Xu J; Liu Q
Oncogene; 2018 Feb; 37(8):1062-1074. PubMed ID: 29106390
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.
Feeley KP; Bray AW; Westbrook DG; Johnson LW; Kesterson RA; Ballinger SW; Welch DR
Cancer Res; 2015 Oct; 75(20):4429-36. PubMed ID: 26471915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
